---
title: "Aryaman Capital Markets Ltd (538716) — Share Price, Financials & Analysis"
symbol: "538716"
company: "Aryaman Capital Markets Ltd"
canonical: "https://tapetide.com/stocks/538716"
isin: "INE229R01011"
nse_symbol: "ARYAMANCAPITALMARKETSLTD"
bse_code: "538716"
sector: "Financial Services"
industry: "Investment Company"
market_cap_cr: 499.5
generated_at: "2026-09-13T20:37:52.598Z"
---

# Aryaman Capital Markets Ltd (538716)

Canonical page: https://tapetide.com/stocks/538716

## Company

- **NSE Symbol:** ARYAMANCAPITALMARKETSLTD
- **BSE Code:** 538716
- **ISIN:** INE229R01011
- **Sector:** Financial Services
- **Industry:** Investment Company
- **Macro Sector:** Financial Services
- **Stock Type:** EQUITY
- **Listed Since:** 2014-10-20
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** afsl.co.in

## About

Aryaman Capital Markets Ltd is the fund-based and secondary-market arm of the Aryaman Group. It undertakes proprietary investments and trading in quoted and unquoted securities, SME market making, underwriting, stock broking and CDSL depository-participant services.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:45:03.445469Z.

- **Market Cap:** ₹499.5 Cr
- **Classification:** Microcap
- **P/E (reported):** 20.3
- **EPS (TTM):** ₹20.54
- **EPS (reported):** ₹5.39
- **Book Value:** ₹90.26
- **Price to Book:** 4.62
- **Dividend Yield:** 0%
- **ROE:** 25.71%
- **ROCE:** 29.59%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹61.6 Cr
- **Net Income:** ₹27.8 Cr
- **EBITDA:** ₹34.2 Cr
- **52-Week High:** ₹633.9
- **52-Week Low:** ₹385.05
- **RSI (14):** 49.38

## Tapetide Score

- **Score:** 55 / 100
- **Score date:** 2026-09-04
- **Archetype:** Losing Momentum
- **What it means:** A capable business whose price trend has turned while the multiple is still demanding. Often a re-rating in progress rather than a broken company — watch whether earnings stay resilient.
- **Pillar profile:** Quality: Good · Valuation: Expensive · Momentum: Falling
- **Percentile:** 70.1 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 86.12 | 9% |
| growth | 3.11 | 9% |
| momentum | 43.09 | 12% |
| ownership | 50 | 24% |
| quality | 81.36 | 22% |
| valuation | 39.44 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 157% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 30.6%
- Company's working capital requirements have reduced from 88.2 days to 35.6 days

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -14.5% over past five years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 21.09% | 283.2% | 258.01% |
| ebitda margin growth | 121.43% | 40.2% | 68.41% | — |
| net income growth | 81.4% | 21.4% | 165% | 157% |
| revenue growth | 17.28% | -20.31% | 10% | -15% |
| roce | — | 7.21% | 136.34% | 16.48% |
| roe | — | -13.23% | 23.68% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 3.52 | 20.79 | 23.8 | 25.7 | 25.72 | 10.43 | 15.44 | 7.69 | 9.28 |
| Expenses | 2.73 | 13.03 | 9.88 | 21.16 | 12.7 | 2.31 | 8.46 | 3.84 | 0.22 |
| Operating Profit | 0.79 | 7.76 | 13.92 | 4.54 | 13.02 | 8.12 | 6.98 | 3.85 | 9.06 |
| OPM % | 22.44 | 37.33 | 58.49 | 17.67 | 50.62 | 77.85 | 45.21 | 50.07 | 97.63 |
| Other Income | 0.6 | 0.68 | 0.81 | 1.43 | 0.47 | 0.96 | 0.68 | 0.38 | 0.22 |
| Interest | 1.04 | 1.02 | 0.93 | 0.61 | 0.65 | 0.3 | 0.01 | 0 | 0 |
| Depreciation | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.25 | 0.04 | 0.04 | 0.04 |
| Profit before tax | 0.33 | 7.39 | 13.77 | 5.33 | 12.81 | 8.53 | 7.61 | 4.19 | 9.24 |
| Tax % | 15.15 | 23.41 | 16.05 | 0 | 13.9 | 21.22 | 24.7 | -2.86 | 15.26 |
| Net Profit | 0.27 | 5.66 | 11.56 | 5.32 | 11.03 | 6.72 | 5.73 | 4.32 | 7.83 |
| EPS in Rs | 0.23 | 4.73 | 9.65 | 4.44 | 9.21 | 5.61 | 4.78 | 3.61 | 6.54 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 28 | 78 | 85 | 135 | 73 | 47 | 34 | 77 | 62 | 43 |
| Expenses | 27 | 75 | 82 | 132 | 70 | 42 | 23 | 47 | 27 | 15 |
| Operating Profit | 1 | 3 | 3 | 3 | 3 | 5 | 11 | 31 | 34 | 28 |
| OPM % | 4.2 | 3.6 | 3.5 | 2.4 | 4 | 11 | 33 | 40 | 56 | 65 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Interest | 1 | 2 | 3 | 3 | 2 | 3 | 4 | 4 | 1 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 2 | 7 | 27 | 33 | 30 |
| Tax % | 2 | 24 | 9 | 26 | 30 | 17 | 14 | 15 | 16 | — |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 1 | 6 | 23 | 28 | 25 |
| EPS in Rs | 0.41 | 0.18 | 0.08 | 0.21 | 0.27 | 1.24 | 5.39 | 19.14 | 23.2 | 20.54 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
| Reserves | 7 | 8 | 8 | 6 | 6 | 6 | 17 | 29 | 65 | 96 |
| Borrowings | 0 | 18 | 32 | 33 | 28 | 31 | 41 | 46 | 28 | 0 |
| Other Liabilities | 1 | 1 | 1 | 0 | 1 | 1 | 2 | 4 | 11 | 10 |
| Total Liabilities | 20 | 39 | 52 | 51 | 47 | 50 | 72 | 91 | 116 | 118 |
| Fixed Assets | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 15 | 23 | 13 | 5 | 4 | 6 | 18 | 26 | 47 | 82 |
| Other Assets | 4 | 15 | 38 | 44 | 41 | 42 | 52 | 64 | 68 | 34 |
| Total Assets | 20 | 39 | 52 | 51 | 47 | 50 | 72 | 91 | 116 | 118 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 7 | -10 | -18 | -4 | 13 | 9 | 7 | 9 | 28 | 34 |
| Cash from Investing Activity | -5 | -7 | 9 | 5 | 1 | -1 | -1 | 2 | -3 | -30 |
| Cash from Financing Activity | -1 | 17 | 12 | -2 | -8 | 0 | 7 | 2 | -22 | -29 |
| Net Cash Flow | 0 | 0 | 3 | -1 | 7 | 8 | 13 | 12 | 4 | -25 |
| Free Cash Flow | 7 | -10 | -19 | -4 | 13 | 9 | 7 | 9 | 28 | 33 |
| CFO/OP | 416 | -805 | -632 | -134 | 404 | 327 | 145 | 81 | 94 | 116 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 0 | 2 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 |
| Inventory Days | 8 | 151 | 150 | 165 | 78 | 108 | 146 | 260 | 134 | 0 |
| Days Payable | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 11 | — |
| Cash Conversion Cycle | 7 | 153 | 151 | 165 | 77 | 108 | 147 | 261 | 124 | 1 |
| Working Capital Days | -2 | -79 | -1 | 163 | 75 | 104 | 133 | 172 | 57 | 36 |
| ROCE % | 9 | 4 | 6 | 6 | 6 | 6 | 8 | 14 | 32 | 32 |

## Shareholding Pattern

### Quarterly

| Category | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 74.28% | 74.28% | 74.28% | 74.28% | 74.28% | 74.28% | 74.28% | 74.28% | 74.28% | 74.28% | 74.28% | 74.28% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 10.39% | 10.1% | 10.12% | 11.21% | 11.29% | 12.48% | 9.88% | 8.3% | 8.24% | 8.06% | 8.01% | 7.98% |
| Others | 15.32% | 15.61% | 15.59% | 14.51% | 14.42% | 13.23% | 15.84% | 17.42% | 17.47% | 17.65% | 17.71% | 17.74% |
| No. of Shareholders | 34 | 33 | 35 | 40 | 41 | 252 | 251 | 299 | 768 | 650 | 583 | 576 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 10 / 5 / 4

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 423.84 | Sell |
| EMA (10) | 422 | Buy |
| SMA (20) | 421.49 | Buy |
| EMA (20) | 419.95 | Buy |
| SMA (50) | 411.53 | Buy |
| EMA (50) | 416.28 | Buy |
| SMA (100) | 419.32 | Buy |
| EMA (100) | 421.02 | Buy |
| SMA (200) | 443.28 | Sell |
| EMA (200) | 416 | Buy |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 53.02 | Neutral |
| MACD (12,26,9) | 3.27 | Sell |
| Stochastic (14,3,3) | 51.22 | Neutral |
| ADX (14) | 38.24 | Buy |
| Williams %R (14) | -40 | Neutral |
| ATR (14) | 17.04 | High Volatility |
| ROC (12) | 1.44 | Buy |
| Stoch RSI (14) | 28.02 | Neutral |
| UO (7,14,28) | 73.22 | Sell |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-03 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2594e9ba-0cd0-4a4b-8465-69b74b79c60a.pdf) |
| 2026-09-02 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87e878d6-b743-46b1-9149-98251f60884e.pdf) |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6bd1213-3e4c-45c7-953d-0a39e1be9622.pdf) |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b8094ee-3fb0-4fbb-af36-92160cce0b0a.pdf) |
| 2026-08-10 | [Board Meeting Outcome for Outcome Of Board Meeting Held On August 10 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83341b7b-dbed-4fa7-ae6a-5a3b64319998.pdf) |
| 2026-08-10 | [Notice Of 18Th Annual General Meeting (AGM) To Be Held On Wednesday September 02 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d2fd415-4fdb-4614-905a-3325ee49b868.pdf) |
| 2026-08-10 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48e66b0d-1f73-4bfb-b1bb-903fb9892a40.pdf) |
| 2026-08-10 | [Intimation Of Book Closure For 18Th Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9458e9b-e2b8-4234-926e-8fbbcd4e24b0.pdf) |
| 2026-08-03 | [Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10d3a88e-db96-4e48-bfd6-7d5dc1373a6b.pdf) |
| 2026-07-31 | [Board Meeting Outcome for Outcome Of Board Meeting Held On July 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df915a7b-e28a-4d57-8c84-9f9b7f27b0a4.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-10 | [Results- Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6075a8ae-79e4-46d4-bd51-725a54680a1c.pdf) |
| 2026-05-18 | [Results For The Financial Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c8ec302c-65d0-46b9-93ab-8720d5faa866.pdf) |
| 2026-02-12 | [Financial Results For The Quarter Ended December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71ee6962-c60d-4c63-a312-2506946b83ba.pdf) |
| 2025-11-12 | [Results - Financial Results For The Quarter Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=104a6721-5360-44f2-a88a-668ec2c644cd.pdf) |
| 2025-08-05 | [Results- Financials For Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b01af177-e3c0-467d-813d-c397bf7e7b01.pdf) |
| 2025-04-29 | [Results For The Financial Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba9084a5-c30e-46a2-a3e2-b63c757d6716.pdf) |
| 2024-11-14 | [Results - Financial Results For September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29b876e4-2acd-4f09-8b62-a439847ab330.pdf) |
| 2024-05-24 | [Results For Financial Year Ended March 31 St , 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8301a034-78a0-4bd2-9eea-1646c94b991d.pdf) |
| 2023-11-09 | [Outcome Of Board Meeting - Submission Of Unaudited Financial Results For Half Year Ended September 30, 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9adda61-42c7-478e-9ce0-b29e44ad9b3c.pdf) |
| 2023-05-26 | [Outcome Of Board Meeting Held On 26Th May, 2023.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f40069e1-34a9-43db-9f01-c7429e3b53f3.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 4 Feb - Board meeting on Feb 12, 2026 to approve unaudited standalone results for quarter ended Dec 31, 2025. | [Board Meeting Intimation for Consideration And Approval Of Unaudited (Standalone) Financial Results For Quarter Ended December 31, 2025 4 Feb - Board meeting on Feb 12, 2026 to approve unaudited standalone results for quarter ended Dec 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1b862023-c286-4920-8196-fe7fd120665a.pdf) |
| 29 November 2025 - Unmodified limited review; related-party transactions and loans disclosed, total closing balances ~₹162.05 million (Nov 28–29, 2025) | [Outcome of Board Meeting 29 November 2025 - Unmodified limited review; related-party transactions and loans disclosed, total closing balances ~₹162.05 million (Nov 28–29, 2025)](https://nsearchives.nseindia.com/corporate/MONO_29112025173106_OUTCOME_WITH_RESULTS_RPT.pdf) |
| 29 November 2025 - Supal Panilam Lakhatariya resigns as Executive Director, becomes Non-Executive Director effective Nov 29, 2025. | [Change in Management 29 November 2025 - Supal Panilam Lakhatariya resigns as Executive Director, becomes Non-Executive Director effective Nov 29, 2025.](https://nsearchives.nseindia.com/corporate/MONO_29112025171600_Reg_30_final.pdf) |
| 29 Apr - Company confirms it is not a large corporate for FY 2026-27. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 29 Apr - Company confirms it is not a large corporate for FY 2026-27.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/14356f11-d209-4bb0-8acf-153fddae8a3f.pdf) |
| 29 Apr - Company confirms it is not a large corporate for FY 2026-27. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 29 Apr - Company confirms it is not a large corporate for FY 2026-27.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/14356f11-d209-4bb0-8acf-153fddae8a3f.pdf) |
| 24 January 2026 - MONO PHARMACARE LIMITED has informed about Resignation of Independent director. | [Resignation of Independent director 24 January 2026 - MONO PHARMACARE LIMITED has informed about Resignation of Independent director.](https://nsearchives.nseindia.com/corporate/MONOPHARMA_ROID_76401_KMP_Doc.zip) |
| 23 January 2026 - Mono Pharmacare Limited has informed regarding Resignation of Mr resignation of Mr. Jitendra Mansukhlal Dasani as Independent Director of the company w.e.f. January 23, 2026. | [Resignation 23 January 2026 - Mono Pharmacare Limited has informed regarding Resignation of Mr resignation of Mr. Jitendra Mansukhlal Dasani as Independent Director of the company w.e.f. January 23, 2026.](https://nsearchives.nseindia.com/corporate/MONO_23012026183816_INTIMATION_OF_RESIGNATION.pdf) |
| 16 Jan - Certificate under Regulation 74(5) of the SEBI (Depository and Participants ) Regulations, 2018 for the quarter ended December 31, 2025. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 16 Jan - Certificate under Regulation 74(5) of the SEBI (Depository and Participants ) Regulations, 2018 for the quarter ended December 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5e3a91d4-a44f-40f9-b7bd-b5a9f4a3977e.pdf) |
| 16 February 2026 - Mono Pharmacare Limited has informed regarding Outcome of Circular Resolution passed by Board of the Company on Monday, February 16, 2026. | [Outcome of Board Meeting 16 February 2026 - Mono Pharmacare Limited has informed regarding Outcome of Circular Resolution passed by Board of the Company on Monday, February 16, 2026.](https://nsearchives.nseindia.com/corporate/MONO_16022026170022_OUTCOME.pdf) |
| 13 Feb - Newspaper Advertisement under Regulation 47 read with Regulation 33 of the SEBI (LODR) Regulations, 2015 | [Announcement under Regulation 30 (LODR)-Newspaper Publication 13 Feb - Newspaper Advertisement under Regulation 47 read with Regulation 33 of the SEBI (LODR) Regulations, 2015](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b82d2632-9288-4810-a34c-016be2c9c22b.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28396_MONOPHARMA_2024_2025_A_1143955_04092025123834.pdf) |
| from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_26166_MONOPHARMA_2023_2024_07092024181332.pdf) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/48e66b0d-1f73-4bfb-b1bb-903fb9892a40.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b59dd7b1-94cc-4eac-9f17-6c7e7fe1f2de.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f13cb735-4eb5-4ba9-9080-7d301bc5f2e3.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c3bdbfd8-59f2-4e4c-aedf-3299d8bd8311.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/538716/75517538716.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/538716/70166538716.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/538716/65839538716.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/538716/5387160319.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T20:37:52.598Z.